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1.  Introduction
Osteoarthritis (OA) is characterized by joint pain, 
tenderness, limitation of movement, crepitus, 
occasional effusion and a variable degree of local 
inflammation. Approximately 10% of the population 
worldwide aged 60 years or older has symptomatic 
problems that can be attributed to OA [1]. Many of 
these patients rely on prescription medications, 
even though their effects are often minimal and 
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can cause severe side effects, such as gastrointes-
tinal bleeding associated with non-steroidal anti-
inflammatory drug use [2]. Owing to the limitations 
of prescribed medication, acupuncture has been 
studied as a novel alternative treatment for OA. The 
positive effects of acupuncture used as OA treat-
ment have been demonstrated in many systematic 
reviews [3,4] and meta-analysis studies [5,6].
Pharmacopuncture is a form of acupuncture in 
which the basic treatment involves stimulation of 
acupoints [7]. Solutions of herbal medicine extracts 
are injected into the acupoints. The mechanical 
stimulation of acupuncture and the chemical effects 
of an herbal medicine are combined to enhance 
and prolong the effects of acupoint access [8].
The root bark of Ulmus davidiana Planch (UDP) 
var. japonica Nakai has long been used by prac-
titioners of Oriental medicine for treatment of 
inflammation. The bark also has analgesic and anti-
edema properties, and has been shown to inhibit 
leukocyte migration [9]. In the present study, the 
herb was used to manufacture pharmacopuncture 
injections and was tested for safety and efficacy 
in OA patients in a double-blind randomized con-
trolled trial.
2.  Materials and Methods
2.1.  Subjects
Patients were recruited by the Department of Acu-
puncture and Moxibustion of Dongguk University, 
Ilsan Hospital through advertisements posted within 
the hospital from August 2008 to December 2008.
Subjects satisfying the following criteria were 
included:
1. At least 40 years of age, but below 80 years of 
age;
2. Presence of knee OA diagnosed by an orthope-
dist based on American College of Rheumatology 
classification criteria;
3. Knee pain from OA in one or both knees rated 
> 4 cm on a 10 cm Visual Analog Scale (VAS);
4. An understanding of the objectives and meth-
ods of the clinical trial, and willingness in com-
pleting the consent form.
Subjects meeting any of the following criteria 
were excluded:
1. A physical or laboratory finding indicating in-
fection, presence of an autoimmune disease, 
or inflammatory arthritis;
2. Trauma to or surgery on the knee(s) within 6 
months prior to enrollment, causing pain or 
functional problems;
3. A history of prolotherapy, injection of hyaluronic 
acid or cortisone within the last 3 months;
4. Serious organic disease, including mental dis-
orders;
5. More severe pain in regions other than the 
knee joint.
After a brief telephone screening, patients were 
asked to visit the hospital to learn about the clin-
ical trial and to sign an informed consent state-
ment. Blood tests (including a complete blood count, 
erythrocyte sedimentation rate, and measurement 
of rheumatoid arthritis factor and uric acid levels), 
and radiographic and physical examinations were 
performed. Statisticians were consulted to randomly 
assign patients into two groups: an UDP pharma-
copuncture group (UDP group) and a normal saline 
injection control group (control group). Allocation 
concealment was maintained by employment of 
opaque sealed envelopes. All subjects, practition-
ers, and the assessor were blind to treatment 
allocation.
2.2.  Procedures
This study was a two-branched parallel double-blind 
randomized controlled trial. The control interven-
tion was adopted from prior studies [10] using nor-
mal saline as the control for pharmacopuncture. 
All subjects went through 2 weeks of screening, 
and received 6 weeks of treatment followed by 
10 weeks of follow-up. The total follow-up period 
was 16 weeks. This study abided by the general 
guidelines of the Declaration of Helsinki. The pro-
tocol was reviewed and approved by the Institu-
tional Review Board of Dongguk University, Ilsan 
Hospital, prior to study commencement.
The treatment intervention was based on tradi-
tional meridian theory and an acupuncture method 
widely used in clinics to treat knee joint pain, 
known as the ‘Bi’ syndrome. Treatment was admin-
istered by two doctors of Oriental medicine with 
extensive clinical experience of pharmacopunc-
ture and the following qualifications:
1. Certified by the Korean Ministry of Health and 
Welfare as an Oriental medicine doctor;
2. More than 1 year of postgraduate clinical train-
ing in an Oriental medicine hospital;
3. Completion of the first-year residency program 
of our Department of Acupuncture and Moxi-
bustion;
4. Graduate of a 6-year full-time course in Orien-
tal medicine, taught as a college program.
Each subject was treated by a single practi-
tioner throughout the 6-week period. Both the UDP 
pharmacopuncture patients and normal saline con-
trol patients received treatment twice a week for 
6 weeks, to yield a total of 12 treatment sessions. 
Four local acupoints on the affected side were used. 
The points used were Dubi (ST35), Xiyan (EX-LE5), 
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Heding (EX-LE2), and Ashi. A pharmacopuncture nee-
dle (29 gauge; 1 mL disposable insulin injection sy-
ringe) was employed. The depth of needle insertion 
was about 5−15 mm for each acupoint. A penetrat-
ing, sharp and painful sensation was induced when 
the skin was broken. A spreading and lumpish sen-
sation around the injection site was also reported. 
If both knees of a patient were affected, both 
knees were treated.
The injection of UDP pharmacopuncture was pro-
duced using extraction via distillation. Dried root 
bark of UDP var. japonica Nakai (200 g) was washed 
and grinded in order to make the active elements 
extract easily. The prepared material was inserted 
into a tubular flow reactor together with 1.5 L of 
water distilled three times. The material was suf-
ficiently soaked before being boiled. The vapor 
was condensed to liquid using a circulative cooling 
system. The obtained solution was refrigerated and 
the top layer was collected. The pH was adjusted 
to 7.3 by using Na3PO4, and the salinity was regu-
lated to be 0.98% by using NaCl. Afterwards the 
solution was filtered, subdivided, sterilized and 
injected into the acupoints using a syringe.
As the control intervention, normal saline was 
used in place of UDP pharmacopuncture to identi-
cally stimulate acupoints, minus the chemical ef-
fects. The needle used, the acupoints selected, the 
depth of needle insertion, and the treatment sched-
ule for the control group were identical with those 
of the UDP group. As normal saline is no different 
in appearance from that of the UDP pharmaco-
puncture preparation, blinding of both patient and 
practitioner was possible. To ensure blinding of the 
patient, practitioner, and assessor, the UDP pharma-
copuncture and normal saline injections were pre-
pared by an independent research assistant.
Patients in both the treatment and control groups 
already taking medication were allowed to maintain 
prior medication until the end of the study. Any 
change of medications in patients of the treatment 
or control groups due to increased pain was reported 
immediately to the research assistant. And use of 
pain killers or patches was monitored and recorded 
by the research assistant on every visit.
A 100 mm VAS to evaluate the severity of pain 
was used as the primary outcome measurement in 
this trial. Secondary outcome measurements were 
obtained using the Western Ontario and McMaster 
Universities (WOMAC) instrument (both the total 
score and the subscores), the KHAQ (Korean Health 
Assessment Questionnaire), and the SF-36 (36-Item 
Short Form Health Survey Instrument). The 0−100 mm 
VAS and WOMAC pain scales were assessed at base-
line, before each treatment, and after 16 weeks. The 
WOMAC, SF-36, and KHAQ scores were assessed at 
baseline and after 3, 6, and 16 weeks. For bilateral 
OA patients, the side with more pain at baseline 
was evaluated throughout the study.
To explore the masking effect of the control 
intervention, participants in the UDP pharmaco-
puncture and control groups were asked which 
treatment they believed they were receiving at 
each session: “true UDP pharmacopuncture”, “nor-
mal saline”, or “uncertain”. Any physical or clinical 
changes, whether or not considered to be related 
to acupuncture (excluding progression of disease), 
were to be reported by the practitioner and pa-
tient at each treatment visit.
2.3.  Statistical analysis
The statistical analysis package SAS version 9.1 
(SAS Institute, Cary, NC, USA) was used. All data of 
patients who complied with the clinical study plan 
were analyzed by the Per-protocol (PP) method, 
and not by Intention-to-treat (IPP). Continuous var-
iables were compared using Student’s t test or a 
paired t test. Discontinuous variables were ana-
lyzed with the Chi-squared test. Statistical signifi-
cance was fixed at p < 0.05.
3.  Results
Of the 107 volunteers, 38 were excluded before 
randomization. This exclusion was due to insuffi-
cient pain (n = 16), severe pain in other parts of the 
body or other serious medical conditions (n = 13), 
or abnormal blood test results indicating that rheu-
matoid arthritis or gout might be present (such as 
elevated rheumatoid arthritis factor or uric acid 
levels; n = 9). Also, nine further patients were ex-
cluded before randomization for personal reasons. 
Thus, the 47 subjects mentioned above were ex-
cluded from statistical analysis. The remaining 60 
subjects were randomly assigned to one of two 
groups. One patient from each group discontinued 
the study for personal reasons. Two patients from 
the normal saline control group were lost to follow-
up owing to a traffic accident. Three additional 
subjects from the control group were excluded 
from statistical analysis because each failed to 
attend assessment visits. Data from 29 subjects in 
the treatment group and 24 in the control group 
were ultimately analyzed (Figure 1).
Among the 53 subjects, 83% were women, and 
55% were aged more than 60 years. There were 
no significant between-group differences in demo-
graphic characteristics or baseline VAS scores, 
suggesting that randomization procedures were 
appropriate and had successfully produced similar 
groups at baseline (Table 1). No cases of increased 
OA medication dosage were reported. The use of 
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painkillers or patches in the two groups showed 
statistically insignificant differences.
Figure 2 shows changes in mean 100 mm pain VAS. 
Figures 3, 4 and 5 indicate changes in mean WOMAC 
pain score, total WOMAC score, and KHAQ score in 
each group. All measurements, except the SF-36 
scores, showed significant improvements in both 
groups. As shown below, VAS was almost the same 
at baseline and during initial treatment. The UDP 
group showed better improvement after the third 
assessment compared with the control group, but 
this was not significant until the sixth assessment. 
After the seventh treatment, the UDP pharmaco-
puncture treatment group (44.1 ± 18.0), compared 
with the control group (55.2 ± 21.6), showed a sig-
nificant difference in pain improvement (p = 0.04). 
However, the between-group difference then 
decreased and was again insignificant.
The WOMAC pain score, total WOMAC score and 
KHAQ score of the UDP group showed improvement 
at the time of the seventh treatment, but between-
group differences were not significant throughout 
the study (Figures 3, 4 and 5).
To evaluate the masking effect of the control 
intervention, participants in the UDP pharmaco-
puncture and control groups were asked which treat-
ment they believed they were receiving at each 
session: “true UDP pharmacopuncture”, “normal 
saline”, or “uncertain”. The number of patients who 
responded “uncertain” was greatest at baseline 
(UDP group 82.8%; control group 70.8%). After the 
13th treatment, the number of subjects who be-
lieved that they were receiving true UDP pharma-
copuncture increased (UDP group 44.8%; control 
group 45.8%). The difference between the two 
groups was not significant, indicating that blinding 
was successful (Tables 2 and 3).
During the 6-week study period, 3 of the 60 
subjects who completed the study reported side 
effects. One subject reported nausea (UDP group), 
Figure 1   Trial flow chart. UDP = Ulmus davidiana Planch.
Assessed for eligibility
(n = 107)
Randomly assigned
(n = 60)
Assigned to receive UDP
pharmacopuncture
(n = 30)
Assigned to normal
saline
(n = 30)
Observation available for
analysis (n = 29)
Observation available for
analysis (n = 24)
Excluded (n = 47)
Insuffucient pain: 16
Severe pain in other parts of
the body or serious medical
condition: 13
Abnormal results on the
blood test: 9
Personal matters: 9
Table 1   Characteristics of the study population
Intervention UDP pharmacopuncture group (n = 29) Normal saline control group (n = 24)
Age (yr) 59.1 ± 9.5 58.5 ± 8.1
Sex (male/female) 6/23 3/21
Affected knees (right/left/both) 9/9/11 9/8/7
Baseline VAS 64.6 ± 3.1 66.8 ± 14.1
UDP = Ulmus davidiana Planch; VAS = visual analog scale.
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Figure 2   Mean 100 mm visual analog scale (VAS) change 
in the Ulmus davidiana Planch (UDP) pharmacopuncture 
group and the normal saline control group. *p = 0.04.
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Figure 4   Mean total Western Ontario and McMaster 
Universities (WOMAC) score change in the Ulmus davidiana 
Planch (UDP) pharmacopuncture group and the normal 
saline control group.
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Figure 5   Mean Korean Health Assessment Questionnaire 
(KHAQ) change in the Ulmus davidiana Planch (UDP) phar-
macopuncture group and the normal saline control group.
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Figure 3 Mean Western Ontario and McMaster Universities 
(WOMAC) pain score change in the Ulmus davidiana Planch 
(UDP) pharmacopuncture group and the normal saline 
control group.
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Table 2   Assessment of blinding at first visit
Guesses at first visit UDP pharmacopuncture group (n = 29) Normal saline control group (n = 24)
UDP pharmacopuncture 2 (6.9%) 7 (29.1%)
Uncertain 24 (82.8%) 17 (70.8%)
Normal saline 3 (10.3%) 0
UDP = Ulmus davidiana Planch.
Table 3   Assessment of blinding at 13th visit
Guesses at 13th visit UDP pharmacopuncture group (n = 29) Normal saline control group (n = 24)
UDP pharmacopuncture 13 (44.8%) 11 (45.8%)
Uncertain 13 (44.8%) 10 (41.7%)
Normal saline 3 (10.3%) 3 (12.5%)
UDP = Ulmus davidiana Planch.
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one itching (UDP group), and one slight dizziness 
(control group). These minor complaints resolved 
in a short time and did not recur. The incidence of 
such symptoms was 5%, indicating that side effects 
were rare. The patients wished to continue treat-
ment, and therefore did not drop out during the 
study.
4.  Discussion
Pharmacopuncture is a recent innovation of tradi-
tional acupuncture that aims to enhance and pro-
long the effects of stimulation of acupoints [8]. 
Pharmacopuncture is also termed “aquapuncture” 
[11] or “herbal acupuncture” [12] and is used in 
Korea, China, and Russia [13−15].
Among the various pharmacopuncture formulae, 
this clinical study used UDP pharmacopuncture be-
cause the dried root bark of UDP var. japonica Nakai 
is known to be effective for treating inflammations 
in Oriental medicine. In fact, recent in vitro and 
in vivo assays have reported UDP to have a positive 
effect for arthritis treatment [16−21].
We sought to determine whether UDP pharma-
copuncture was effective in patients suffering OA 
of the knee. Our findings indicate that UDP phar-
macopuncture was effective in improving VAS-rated 
pain after the seventh treatment (in the third week), 
compared with normal saline. It has been reported 
that traditional acupuncture requires 6−8 weeks of 
treatment before development of significant ef-
fects when used to treat OA of the knee [22]. The 
studies by Witt et al [23], Williamson et al [24], 
Berman et al [25], and Miller et al [26] ranging from 
7 to 12 weeks all support this idea. However, the 
pharmacopuncture used in the present study was 
administered over seven treatment sessions within 
3 weeks in an effort to show a significant difference 
between test and control groups. This is shorter 
than traditional acupuncture treatments. However, 
pharmacopuncture may be stron ger than tradi-
tional acupuncture [8]. The chemical effects of 
UDP solution have been reported in recent in vitro 
and in vivo studies [16−21].
Overall, the results showed that only VAS-rated 
pain (after the seventh treatment) showed a sig-
nificant between-group difference and that all 
other outcomes (WOMAC-, total WOMAC-, SF-36-, 
and KHAQ-rated pain) were similar in both groups. 
One possible reason is that the normal saline group 
may not have been a suitable placebo control. 
A placebo in a clinical trial should appear to be real, 
but must be inert [27,28]. UDP pharmacopuncture 
and normal saline were identical in appearance and 
the patient-masking effect was successful (Tables 2 
and 3). However, the inertness of normal saline is 
debatable. In a prolotherapy study on musculoskel-
etal disease, normal saline injection showed the 
same treatment effects as did prolotherapy [29,30]. 
Also, in studies of joint lavage [31−33], the control 
group intervention, a normal saline injection, im-
proved VAS-assessed pain. Normal saline injection 
into the P6 acupoint was also found to be as effec-
tive as droperidol in controlling nausea and vomit-
ing [34]. Many earlier pharmacopuncture studies 
[10,35−39] used normal saline injection as a con-
trol group intervention owing to the identical ap-
pearance of test and control solutions. We followed 
the recognized placebo design; however, just as 
minimal acupuncture was concluded to be an in-
valid placebo control for randomized controlled tri-
als of acupuncture in a physiological setting [28], 
normal saline injection might not be a valid control 
intervention for pharmacopuncture studies because 
the injection has a pain-relieving effect.
The effects of pharmacopuncture treatment 
are a combination of placebo, needle stimulation, 
Figure 6   Effect of Ulmus davidiana Planch (UDP) pharmacopuncture compared with normal saline injection.
Mechanical
effect of solution
Needle
stimulation effect
Placebo effect
UDP pharmacopuncture Normal saline
Mechanical
effect of solution
Needle
stimulation effect
Placebo effect
Chemical
effect of
UDP
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mechanical effects of the solution, and the chem-
ical effects of UDP. However, normal saline in-
jection also has the first three effects, perhaps 
rendering saline inappropriate as a control placebo 
intervention.
In summary, UDP pharmacopuncture, compared 
with normal saline injection, caused pain improve-
ment after the seventh treatment session, but over-
all, differences were generally insignificant. This 
may be due to the inappropriateness of the control 
intervention. For accurate reassessment of phar-
macopuncture, an inert control intervention such 
as dry needling or a waiting list control should be 
used in future studies. Also, more work on efficient 
extraction and concentration of useful components 
in UDP are needed. Furthermore, pharmacopunc-
ture is usually applied together with traditional 
acupuncture in clinical practice. Therefore, a fur-
ther study investigating the effects of a combi-
nation of acupuncture and pharmacopuncture is 
required.
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